ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

Moderna chief predicts existing vaccines will struggle with omicron

Stephane Bancel foresees 'material drop' in effectiveness of current jabs against new variant

It will take several months before pharma companies can manufacture new variant-specific jabs at scale, according to Stephane Bancel, the chief executive of Moderna.   © AP

CAMBRIDGE, Mass. (Financial Times) -- The chief executive of Moderna has predicted that existing vaccines will be much less effective at tackling omicron than earlier strains of Covid-19 and warned it would take months before pharmaceutical companies can manufacture new variant-specific jabs at scale.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more